XML 30 R21.htm IDEA: XBRL DOCUMENT v3.21.2

Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2021

Financial Instruments

Schedule of Contingent consideration

​

​	​	​	​	​	​	​	​	​
​	​	2021					​	2020
​	​	Diabetes	​	​	​	​	​	​
​		alliance	​	Other	​	Total	​	Total
​	​	$m	​	$m	​	$m	​	$m
At 1 January		2,932	​	391	​	3,323	​	4,139
Settlements		(304)	​	(5)	​	(309)	​	(353)
Revaluations	​	82	​	–	​	82	​	(44)
Discount unwind		99	​	13	​	112	​	141
At 30 June		2,809	​	399	​	3,208	​	3,883

X

- Definition

The disclosure of contingent liabilities in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2020-01-01
-Paragraph B64
-Subparagraph j
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2020-en-r&anchor=para_B64_j&doctype=Appendix&subtype=B
-URIDate 2020-01-01

+ Details

Name:	ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfFinancialInstrumentsAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration